Royal College of Nursing cuts ties with Israeli drug company Britain’s nursing union axes Teva UK as commercial partner over links to Israel’s military and corporate track record The Guardian - UK · Oct 2
Nine More Drugmakers Join the Medicaid Pricing Deals, and the Effect on Your Pharmacy Bill Is Limited Nine more drugmakers signed most-favored-nation Medicaid pricing deals, bringing the total to 26. Here is what changes and what does not. Medical Daily · Sep 2
Trump Has Now Struck Drug Pricing Deals With 26 Companies. They Cover Nearly 90% Of The Branded Drug Market. Nine midsize drugmakers joined the White House program and pledged at least $19.6 billion in U.S. manufacturing investments. International Business Times · Sep 1
Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of companies to twenty-six manufacturers. The deals cover medicines for chronic and rare diseases, benefiting Medicaid programs. Sun Pharma will contribute antibiotics to the US Strategic Active Pharmaceutical Ingredients Reserve. These… The Economic Times · Aug 31
FDA recall of blood pressure pills due to cancer-causing contaminant may point to higher safety risks in older generic drugs A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines. The Conversation · Nov 7, 2025
Blood Pressure Medication Recalled Because Of Cancer Risk: What Is Prazosin Hydrochloride Teva Pharmaceuticals orders a nationwide recall of their Prazosin Hydrochloride capsules. International Business Times UK · Oct 31, 2025
Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp? MarketBeat · Feb 3, 2025
2 Generic Drug Stocks Ready to Surge in 2025 Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success. MarketBeat · Nov 27, 2024
New Generic Diabetes Drug Shows How Medical Innovation Works The drugmaker Teva Pharmaceuticals made history in June by launching the first-ever generic version of a GLP-1 diabetes drug. International Business Times · Jul 29, 2024
Teva Pharmaceuticals Stock Has Unusual Call Options Activity After Its Q1 Results Teva Pharmaceuticals, the generic drug maker, posted good Q1 results today, reaffirming its forecast for significant free cash flow in 2024. That led to unusual call options activity based on a Barchart report. Barchart · May 8, 2024
Teva to pay $225M to settle cholesterol drug price-fixing charges The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a widely used cholesterol-lowering drug The Independent UK · Aug 21, 2023